DIN 02491753 — DOVATO 300 MG; 50 MG
DOVATO is a tablet of Dolutegravir / Lamivudine marketed by VIIV HEALTHCARE ULC. The full Dolutegravir / Lamivudine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02491753
- Brand name
- DOVATO
- Active ingredient
- Dolutegravir / Lamivudine
- Strength
- 300 MG; 50 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- VIIV HEALTHCARE ULC
- Health Canada status
- MARKETED
- Drug class
- Antiretroviral combination (integrase strand transfer inhibitor + nucleoside reverse transcriptase inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.